$599

Novo ObesityWeek 2026 Presentations; MiniMed Fit FDA Clearance; Corxel Ph2 Oral GLP-1RA Results

Three cardiometabolic-related news items have been observed: Novo presented additional Ph3 results of cagrisema at ObesityWeek 2026 (view press release); MiniMed received FDA clearance for MiniMed Fit (view press release); and Corxel shared full Ph2 data of its oral GLP-1RA for obesity (view press release). Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Already a member? Log in here